CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome-Reference-Cited by-同舟云学术

CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome

Published:2012-03 Issue:3 Volume:43 Page:364-373
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Idowu Michael O.,Kmieciak Maciej,Dumur Catherine,Burton Regina S.,Grimes Margaret M.,Powers Celeste N.,Manjili Masoud H.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference40 articles.

1. First among equals: the cancer cell hierarchy;Ichim;Leuk Lymphoma,2006

2. Cancer as an evolutionary and ecological process;Merlo;Nat Rev Cancer,2006

3. Breast tumor heterogeneity: cancer stem cells or clonal evolution;Campbell;Cell Cycle,2007

4. Stem cells, cancer, and cancer stem cells;Reya;Nature,2001

5. Cancer stem cells—an old idea that's new again: implications for the diagnosis and treatment of breast cancer;Song;Expert Opin Biol Ther,2007

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11

2. Design, Synthesis, and biological evaluation of copper(II) complexes with phenanthroline-based ligands as potential anticancer agents;Journal of Coordination Chemistry;2024-09-10

3. ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer;Oncogene;2024-09-09

4. An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates;Molecular Pharmaceutics;2024-07-24

5. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer;Breast Cancer Research and Treatment;2024-07-17